Skip to main content

Table 1 Baseline patient demographics and clinical characteristics

From: A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Variable

Measure

Total (N = 12)

Age (years)

Mean (SD)

27.3 (2.38)

Median

27.0

Range

23.0–31.0

95% confidence interval

(25.7, 28.8)

Gender

Female

6 (50.0%)

Male

6 (50.0%)

Race

Asian

3 (25.0%)

Caucasian

6 (50.0%)

Other

3 (25.0%)

Height (m)

Mean (SD)

1.7 (0.11)

Median

1.7

Range

1.6–1.9

95% confidence interval

(1.6, 1.8)

Weight (kg)

Mean (SD)

68.5 (17.91)

Median

61.4

Range

46.1–113.3

95% confidence interval

(57.1, 79.9)

BMI (kg/m2)

Mean (SD)

23.8 (4.47)

Median

23.2

Range

18.6–35.8

 

95% confidence interval

(20.9, 26.6)

  1. BMI body mass index, SD standard deviation